INTERCONTINENTALEXCHANGE, INC./CBOT HOLDINGS, INC.
Filed by IntercontinentalExchange, Inc.
Pursuant to Rule 425 under the
Securities Act of 1933, as amended, and
deemed filed pursuant to Rule 14a-6 under the
Securities Exchange Act of 1934, as amended
Subject Company:
CBOT Holdings, Inc.
(Commission File No. 001-32650)
|
|
|
|
|
PRESS RELEASE |
ICE SENDS LETTER TO CBOT STOCKHOLDERS
URGING THEM TO REJECT CME PROPOSAL
Says CMEs Supposedly Enhanced Offer Has Been Raised by
Less Than the Increase in CBOTs 2007 Earnings Outlook
Atlanta, GA (June 27, 2007) IntercontinentalExchange, Inc. (NYSE: ICE) today sent the following
letter to Chicago Board of Trade (NYSE: BOT) stockholders and members urging them to reject the
proposed sale to CME:
June 27, 2007
DONT BE SOLD SHORT BY YOUR BOARD AGAIN STOP CME
FROM BUYING CBOT ON THE CHEAP
CMES SUPPOSEDLY ENHANCED OFFER HAS BEEN RAISED BY LESS THAN THE
INCREASE IN CBOTS 2007 EARNINGS OUTLOOK
VOTE NO ON CMES CLEARLY INFERIOR OFFER ON JULY 9
Dear Chicago Board of Trade Stockholder/Member:
Your Board has agreed to sell CBOT to CME in a transaction that significantly undervalues your
company. Rather than match ICEs higher offer, CME has yet again low-balled you with a supposedly
enhanced offer that doesnt reflect the true value of your company and will be paid for by
CBOTs own improved earnings prospects. Instead of putting their money on the table, CME has
continued to wage a campaign of low-road rhetoric in an attempt to scare you into voting for their
inferior transaction.
THE CHOICE IS CLEAR:
ICE HAS CONSISTENTLY OFFERED YOU MORE VALUE FOR CBOT
By voting NO on July 9th, you can stop this inferior deal and send a message to
your Board that you want it to consider ICEs superior proposal.
CMES INCREASED BID IS BEING PAID FOR BY
CBOTS OWN IMPROVING EARNINGS PROSPECTS
Before ICE made its competing bid, the CBOT Board had agreed to sell your Exchange to the CME in a
transaction that was then worth $151.28 per CBOT share. Since then, CBOTs consensus EPS estimates
have risen by 25% for 2007 and 22% for 2008. Yet CME has only increased its original bid by 22%:
16% on May 11 with a higher exchange ratio, and 6% on June 14 through a contingent special
dividend. And you wouldnt have gotten even this apparent increase from the CME without ICEs
superior proposal. Over the same period, CMEs 2007 and 2008 consensus EPS estimates have
increased by just 2% and 3%, respectively. Its a sweet deal for the slow-growing CME but a bad
deal for you.
ICE HAS A DEMONSTRABLY STRONGER CURRENCY
CME has consistently tried to talk down the value of ICEs stock by dismissing ICEs superior
growth rate and strong fundamentals. The fact is that ICE has been growing rapidly and profitably,
both organically and through strategic acquisitions which is reflected in its strong share price
appreciation. Yet ICE shares continue to trade at a lower multiple than CME which indicates future
upside. The CME doesnt want you to realize that its growth rate is lower, its multiple is higher,
and its stock is less liquid.
This graph demonstrates how ICE has created more value for stockholders than CME. Which stock
would you rather own?
2
|
|
ICE CREATES MORE VALUE: |
|
|
|
Since ICE proposed to merge with CBOT in March, CBOT shares are up by $34.33
per share, increasing value for CBOT stockholders by $1.8 billion. |
|
|
|
|
Since going public, ICE shares are up 460% versus only 37% for the CME over the
same period. |
|
|
|
|
ICEs stock offers greater liquidity: average dollar volume traded in 2007 is
$583 million per day for ICE vs. only $375 million per day for CME. |
|
|
|
|
In response to member requests for a cash option, ICE enhanced its all-stock
offer to include a $2.5 billion cash election. |
|
|
|
|
ICE worked with the CBOE to craft a win-win solution to the exercise right
issue only after ICE took this innovative action did CME attempt to copy ICE with an
inferior version of the ICE/CBOE proposal to CBOT members. |
|
|
ICE HAS CONTINUED TO DEMONSTRATE VISION & LEADERSHIP: |
|
|
|
Quickly and successfully integrated the NYBOT acquisition, generating record trading volume |
|
|
|
|
Acquired the exclusive license for Russell Index futures these are longtime CME-traded products |
|
|
|
|
Partnered with NGX to offer NGXs contracts on ICEs platform and bring NGXs
capabilities for physical settlement of energy contracts to the U.S. |
|
|
|
|
Announced the acquisition of ChemConnects trading business |
|
|
|
|
Announced the acquisition of Winnipeg Commodity Exchange and its leading canola
futures product |
ICEs management is committed to the success of an ICE/CBOT merger, and will apply to the combined
company the innovation and leadership that has made ICE the fastest growing derivative exchange in
the world. An ICE/CBOT combination is an important step in creating the worlds leading derivative
exchange. ICE is committed to continue innovating and creating new markets instead of relying
solely on the protection of large market positions in developed products.
INTEGRATION RISK IS A RED HERRING JUDGE THE FACTS FOR YOURSELF
Rather than paying you what CBOT is worth, CME and your Board have attempted to push through their
below-market transaction by attacking an ICE/CBOT merger as risky and a threat to your franchise
and livelihood. Lets look at the facts:
|
|
In 2006, the ICE system was available 99.99% of the time, among the best records in the industry. |
|
|
|
The ICE platform is available 7 days a week, 23 hours a day. |
|
|
|
ICE currently averages 27 milliseconds for a round-trip futures trade and expects to improve to 7 milliseconds by
August. A CME round trip averages 31 milliseconds. |
|
|
|
Multiple distribution points make ICE the worlds most accessible trading platform. |
|
|
|
ICE is built on new not legacy technologies, yielding greater cost efficiencies, high reliability, performance,
speed and functionality. All at the lowest possible cost, which is critical for competitiveness in global markets. |
|
|
|
The previous integration of CBOT clearing into the CME common clearing link was complicated, but was accomplished in
only nine months. It is disingenuous of CBOT and CME to claim we will be unable to integrate these platforms in a
timely fashion. |
Why would ICE jeopardize over $10 billion of market capitalization if a merger with CBOT were truly
risky?
ICEs senior management has a lot of skin in the game. We own over 2.8 million ICE shares, or more
than 4.1% of the Company, and are personally invested in the success of ICE and a combined
ICE/CBOT. Would ICE be pursuing this combination if we were not completely confident in our
ability to integrate and grow a combined ICE/CBOT?
3
In sharp contrast, the combined ownership of CME by all 30 CME executive management and Board
members is 356,797 shares, or only 1.0% of CME. The CEO and Chairman of CME together beneficially
own all of 81,910 CME shares, or just 0.2% of CME, and most of these are options.
PRESERVE YOUR RIGHT TO OBTAIN FAIR VALUE FOR YOUR EXCHANGE!
VOTE AGAINST THE CME/CBOT TRANSACTION
If you want to protect your opportunity to receive more value for your shares through the ICE
proposal, we urge you to reject the undervalued CBOT sale to CME. A distinguished institution such
as CBOT, its stockholders, and its members deserve better.
On behalf of the ICE Board and management team, thank you for your continued support.
Sincerely,
Jeffrey C. Sprecher
Chairman and Chief Executive Officer
IntercontinentalExchange, Inc.
VOTE AGAINST THE CME PROPOSAL TODAY!
Even if you have already returned a proxy you have every right to change your
vote. Only your latest dated vote will count. We urge CBOT Stockholders to vote
AGAINST the CMEs below-market offer.
If you have any questions, please contact:
M&A Incorporated
Toll-Free at: (877) 800-5187
Additional Information
More information about the ICE proposal is available on the ICE website at www.theice.com under
About ICE/Investor Relations and at www.theicecbot.com. In addition, ICE will post slides entitled
Revised Proposal to Acquire CBOT Holdings dated June 12, 2007 to its website under About
ICE/Investor Relations and on www.theicecbot.com.
About IntercontinentalExchange
IntercontinentalExchange® (NYSE: ICE) operates the leading global, electronic
marketplace for trading both futures and OTC energy contracts and the leading soft commodity
4
exchange. ICEs markets offer access to a range of contracts based on crude oil and refined
products, natural gas, power and emissions, as well as agricultural commodities including cocoa,
coffee, cotton, ethanol, orange juice, wood pulp and sugar, in addition to currency and index
futures and options. ICE® conducts its energy futures markets through its U.K. regulated
London-based subsidiary, ICE Futures, Europes leading energy exchange. ICE Futures offers liquid
markets in the worlds leading oil benchmarks, Brent Crude futures and West Texas Intermediate
(WTI) Crude futures, trading nearly half of the worlds global crude futures by volume of commodity
traded. ICE conducts its agricultural commodity futures and options markets through its U.S.
regulated subsidiary, the New York Board of Trade®. For more than a century, the
NYBOT® has provided global markets for food, fiber and financial products. ICE was
added to the Russell 1000® Index on June 30, 2006. Headquartered in Atlanta, ICE also
has offices in Calgary, Chicago, Houston, London, New York and Singapore. For more information,
please visit www.theice.com and www.nybot.com.
Forward-Looking Statements - Certain statements in this press release may contain forward-looking
information regarding IntercontinentalExchange, Inc., CBOT Holdings, Inc., and the combined company
after the completion of the possible merger that are intended to be covered by the safe harbor for
forward-looking statements provided by the Private Securities Litigation Reform Act of 1995.
These statements include, but are not limited to, statements about the benefits of the merger
transaction involving ICE and CBOT, including future strategic and financial benefits, the plans,
objectives, expectations and intentions of ICE following the completion of the merger, and other
statements that are not historical facts. Such statements are based upon the current beliefs and
expectations of ICEs management and are subject to significant risks and uncertainties. Actual
results may differ materially from those set forth in the forward-looking statements.
The following factors, among others, could cause actual results to differ materially from those
expressed or implied in such forward-looking statements regarding the success of the proposed
transaction: the failure of CBOT to accept ICEs proposal and enter into definitive agreements to
effect the transaction, the risk that the revenue opportunities, cost savings and other anticipated
synergies from the merger may not be fully realized or may take longer to realize than expected;
superior offers by third parties; the requisite approvals provided for under the Agreement dated
May 30, 2007, as amended on June 11, 2007, by and between ICE and the Chicago Board Options
Exchange (CBOE), and the performance of the obligations under such Agreement; the ability to
obtain governmental approvals and rulings on or regarding the transaction on the proposed terms and
schedule; the failure of ICE or CBOT stockholders to approve the merger; the risk that the
businesses will not be integrated successfully; disruption from the merger making it difficult to
maintain relationships with customers, employees or suppliers; competition and its effect on
pricing, spending and third-party relationships and revenues; social and political conditions such
as war, political unrest or terrorism; general economic conditions and normal business uncertainty.
Additional risks and factors are identified in ICEs filings with the Securities and Exchange
Commission (the SEC), including ICEs Annual Report on Form 10-K for the year ended December 31,
2006, as filed with the SEC on February 26, 2007 and ICEs Quarterly Report on Form 10-Q for the
quarter ended March 31, 2007, as filed with the SEC on May 4, 2007.
You should not place undue reliance on forward-looking statements, which speak only as of the date
of this press release. Except for any obligations to disclose material information under the
Federal securities laws, ICE undertakes no obligation to publicly update any forward-looking
statements to reflect events or circumstances after the date of this press release.
Important Information About the Proposed Transaction and Where to Find It:
5
This material relates to a business combination transaction with CBOT proposed by ICE, which may
become the subject of a registration statement filed with the SEC. This material is not a
substitute for the joint proxy statement/prospectus that CBOT and ICE would file with the SEC if
any agreement is reached or any other documents which ICE may send to stockholders in connection
with the proposed transaction. INVESTORS ARE URGED TO READ THE JOINT PROXY STATEMENT/PROSPECTUS AND
ALL OTHER RELEVANT DOCUMENTS IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT
INFORMATION. Investors will be able to obtain a free copy of the joint proxy statement/prospectus,
if and when such document becomes available, and related documents filed by ICE or CBOT without
charge at the SECs website (http://www.sec.gov). Copies of the final proxy statement/prospectus,
if and when such document becomes available may be obtained, without charge, from ICE by directing
a request to ICE at 2100 RiverEdge Parkway, Suite 500, Atlanta, Georgia, 30328, Attention: Investor
Relations; or by emailing a request to ir@theice.com.
ICE has filed a proxy statement in connection with the special meeting of CBOT stockholders
scheduled for July 9, 2007, at which the CBOT stockholders will consider the CBOT merger agreement
with CME and other related matters. CBOT stockholders are strongly advised to read this proxy
statement and other related documents, as they contain important information. Investors are able to
obtain a free copy of the proxy statement with respect to the special meeting without charge, at
the SECs website (http://www.sec.gov). Copies of the proxy statement with respect to the special
meeting may be obtained, without charge, from ICE by directing a request to ICE at 2100 RiverEdge
Parkway, Suite 500, Atlanta, Georgia, 30328, Attention: Investor Relations; or by emailing a
request to ir@theice.com.
This communication shall not constitute an offer to sell or the solicitation of an offer to buy the
securities, nor shall there be any sale of securities in any jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or qualification under the securities
laws of any such jurisdiction. No offering of securities shall be made except by means of a
prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended.
Participants in the Solicitation:
In addition to ICE, the following officers and employees of ICE will also be participants in the
foregoing proxy solicitations: Jeffrey C. Sprecher (Chairman and Chief Executive Officer), David S.
Goone (Senior Vice President, Chief Strategic Officer) and Kelly L. Loeffler (Vice President,
Investor Relations and Corporate Communications).
You can find information about ICE and ICEs directors and executive officers in ICEs Annual
Report on Form 10-K, filed with the SEC on February 26, 2007 and in ICEs proxy statement for its
2007 annual meeting of stockholders, filed with the SEC on March 30, 2007.
Other than 1,000 shares of CBOT Class A Common Stock owned by ICE, neither ICE nor any of the other
participants in either of these proxy solicitations has any interest, direct or indirect, by
securities holdings or otherwise, in CBOT Holdings, Inc. or Chicago Mercantile Exchange Holdings
Inc. None of the participants will receive any special compensation in connection with either of
these proxy solicitations.
Contact:
IntercontinentalExchange:
Kelly Loeffler
VP, Investor Relations and Corporate Communications
(770) 857-4726
kelly.loeffler@theice.com
Sard Verbinnen & Co
Jim Barron/Kara Findlay
(212) 687-8080
Brad Wilks
(312) 895-4700
Crystal Clear Communications
Ellen G. Resnick
(773) 929-9292; (312) 399-9295 (c)
eresnick@crystalclearPR.com
6